To test this possibility, we performed epistasis analysis in ER-positive breast tumors in the METABRIC dataset and still observed mutual exclusivity (p = 0.0009, odds.ratio = 0.32, CI = 0.134, 0.679) of CBFB and TP53 mutations (Fig 1C). Here, CBFB is linked to breast neoplasm.